NCT05674123

Brief Summary

This clinical trial assesses the safety and effectiveness of a new device called the Flex Robotic System in the surgical removal (resection) of colorectal lesions. When an area of abnormal tissue called a lesion is found in the colon or rectum, it is often not known if the lesion is cancerous or non-cancerous. Recommendation to remove the lesion may be made. Current methods of resection can be challenging and time-consuming. The Flex Robotic System is a new device that provides a stable working environment, better ability to grasp and cut lesions, and better tissue handling when performing a resection. The Flex Robotic system may be more effective at removing colorectal lesions than standard resection techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
Last Updated

January 12, 2023

Status Verified

December 1, 2022

Enrollment Period

2.4 years

First QC Date

December 12, 2022

Last Update Submit

January 11, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rates of complete en bloc resection

    Rates of complete en bloc resection

    Up to 2 years

  • Incidence of adverse events

    The primary endpoint will be the Incidence of adverse events using the Flex Robotic System for distal colorectal lesions.

    Up to 2 years

Study Arms (1)

Device Feasibility (Flex Robotic System)

EXPERIMENTAL

Patients undergo resection with Flex Robotic System on study. Patients also undergo colonoscopy with or without rectal endoscopic ultrasound at screening.

Procedure: ColonoscopyProcedure: Endoscopic UltrasoundOther: Medical Chart ReviewOther: Medical Device Usage and EvaluationProcedure: Resection

Interventions

ColonoscopyPROCEDURE

Undergo colonoscopy

Device Feasibility (Flex Robotic System)

Undergo rectal endoscopic ultrasound

Also known as: endosonography, EUS
Device Feasibility (Flex Robotic System)

Ancillary studies

Also known as: Chart Review
Device Feasibility (Flex Robotic System)

Undergo resection with the Flex Robotic System

Device Feasibility (Flex Robotic System)
ResectionPROCEDURE

Undergo resection with the Flex Robotic System

Also known as: Robot-assisted surgical Resection
Device Feasibility (Flex Robotic System)

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>= 22 years (minimum age approved for use)
  • Polypoid (0-Is) and non-polypoid (0-IIa, 0-IIb and 0-IIc) lateral spreading lesions according to Paris classification
  • Colorectal lesions situated between 5 and 15 cm from the dentate line
  • Colorectal mucosal lesions ranging from 1.5 to 7 cm in maximum diameter
  • Colorectal subepithelial lesions \< 2 cm in size
  • Absence of uncorrectable bleeding disorder or coagulopathy
  • Platelet count \> 50,000
  • International normalized ratio (INR) \< 1.5
  • Ability to give informed consent

You may not qualify if:

  • Inability to receive general anesthesia
  • Presence of medical conditions for which a transanal approach is contraindicated (e.g., anal stricture, radiation proctopathy)
  • Excavated (0-III) colorectal lesions according to Paris classification
  • Suboptimal colon preparation
  • Clinical discretion of the provider

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

ColonoscopyEndoscopic Ultrasound-Guided Fine Needle Aspiration

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresBiopsy, Fine-NeedleBiopsy, NeedleBiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesImage-Guided BiopsySpecimen HandlingUltrasonography, InterventionalUltrasonographyDiagnostic ImagingInvestigative Techniques

Study Officials

  • Louis M Wong Kee Song

    Mayo Clinic in Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2022

First Posted

January 6, 2023

Study Start

January 15, 2020

Primary Completion

June 10, 2022

Study Completion

June 10, 2022

Last Updated

January 12, 2023

Record last verified: 2022-12

Locations